Pallavi Subramanian1, Ioannis Mitroulis, George Hajishengallis, Triantafyllos Chavakis. 1. aDepartment of Clinical Pathobiochemistry, University Clinic Carl Gustav Carus, TU Dresden, Dresden, Germany bDepartment of Microbiology, Penn Dental Medicine, University of Pennsylvania, Philadelphia, USA *Pallavi Subramanian and Ioannis Mitroulis contributed equally to the writing of this article.
Abstract
PURPOSE OF REVIEW: Neutrophils have traditionally been viewed in the context of acute infection and inflammation forming the first line of defense against invading pathogens. Neutrophil trafficking to the site of inflammation requires adhesion and transmigration through blood vessels, which is orchestrated by adhesion molecules, such as β2 and β1-integrins, chemokines, and cytokines. The review focuses on recent advances in understanding the regulators of neutrophil recruitment during inflammation in both acute and chronic settings. RECENT FINDINGS: Recent findings suggest that besides the established pathways of selectin or chemokine-mediated integrin activation, signaling by distinct Toll-like receptors (TLRs) (especially TLR2, TLR4, and TLR5) can activate integrin-dependent neutrophil adhesion. Moreover, the integrin α3β1 has been vitally implicated as a new player in neutrophil recruitment and TLR-mediated responses in septic inflammation. Furthermore, several endogenous inhibitory mechanisms of leukocyte recruitment have been identified, including the secreted molecules Del-1, PTX3, and GDF-15, which block distinct steps of the leukocyte adhesion cascade, as well as novel regulatory signaling pathways, involving the protein kinase AKT1 and IFN-λ2/IL-28A. SUMMARY: The leukocyte adhesion cascade is a tightly regulated process, subjected to both positive and negative regulators. Dysregulation of this process and hence neutrophil recruitment can lead to the development of inflammatory and autoimmune diseases.
PURPOSE OF REVIEW: Neutrophils have traditionally been viewed in the context of acute infection and inflammation forming the first line of defense against invading pathogens. Neutrophil trafficking to the site of inflammation requires adhesion and transmigration through blood vessels, which is orchestrated by adhesion molecules, such as β2 and β1-integrins, chemokines, and cytokines. The review focuses on recent advances in understanding the regulators of neutrophil recruitment during inflammation in both acute and chronic settings. RECENT FINDINGS: Recent findings suggest that besides the established pathways of selectin or chemokine-mediated integrin activation, signaling by distinct Toll-like receptors (TLRs) (especially TLR2, TLR4, and TLR5) can activate integrin-dependent neutrophil adhesion. Moreover, the integrin α3β1 has been vitally implicated as a new player in neutrophil recruitment and TLR-mediated responses in septic inflammation. Furthermore, several endogenous inhibitory mechanisms of leukocyte recruitment have been identified, including the secreted molecules Del-1, PTX3, and GDF-15, which block distinct steps of the leukocyte adhesion cascade, as well as novel regulatory signaling pathways, involving the protein kinase AKT1 and IFN-λ2/IL-28A. SUMMARY: The leukocyte adhesion cascade is a tightly regulated process, subjected to both positive and negative regulators. Dysregulation of this process and hence neutrophil recruitment can lead to the development of inflammatory and autoimmune diseases.
Authors: Konstantin Stark; Annekathrin Eckart; Selgai Haidari; Anca Tirniceriu; Michael Lorenz; Marie-Luise von Brühl; Florian Gärtner; Alexander Georg Khandoga; Kyle R Legate; Robert Pless; Ingrid Hepper; Kirsten Lauber; Barbara Walzog; Steffen Massberg Journal: Nat Immunol Date: 2012-11-25 Impact factor: 25.606
Authors: Sapna Devi; Anqi Li; Clare L V Westhorpe; Camden Y Lo; Latasha D Abeynaike; Sarah L Snelgrove; Pam Hall; Joshua D Ooi; Christopher G Sobey; A Richard Kitching; Michael J Hickey Journal: Nat Med Date: 2012-12-16 Impact factor: 53.440
Authors: Otto Lindemann; Daniel Umlauf; Svetlana Frank; Sandra Schimmelpfennig; Jessica Bertrand; Thomas Pap; Peter J Hanley; Anke Fabian; Alexander Dietrich; Albrecht Schwab Journal: J Immunol Date: 2013-05-01 Impact factor: 5.422
Authors: Katia De Filippo; Anne Dudeck; Mike Hasenberg; Emma Nye; Nico van Rooijen; Karin Hartmann; Matthias Gunzer; Axel Roers; Nancy Hogg Journal: Blood Date: 2013-05-03 Impact factor: 22.113
Authors: Ioannis Kourtzelis; Ioannis Mitroulis; Janusz von Renesse; George Hajishengallis; Triantafyllos Chavakis Journal: J Leukoc Biol Date: 2017-03-14 Impact factor: 4.962